Suven Life Sciences Ltd share price logo

Suven Share Price (SUVEN)

₹236.62.34%

as on

| Source : NSE

bell
The current prices are delayed by 15 mins, login to check live prices.

Suven Stock Performance

as on August 19, 2025 at 4:01 PM IST

  • Day's Low

    Day's High

    ₹227
    ₹242.7
    downward going graph

    4.06%

    Downside

    2.58%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    ₹102.5
    ₹299.99
    downward going graph

    56.68%

    Downside

    26.79%

    Upside

    downward going graph
Previous Close₹231.20
Open₹231.00
Volume1.12L
Upper Circuit₹242.75
Lower Circuit₹219.65
Day's Low227
Day's High242.7
52 Week Low102.5
52 Week High299.99
1 Month Return-17.39 %
3 Month Return+ 15.06 %
1 Year Return+ 63.27 %
3 Year Return+ 244.9 %
5 Year Return+ 375.58 %

Suven Stock Fundamentals & Key Indicators

Check Suven market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

₹5,159.62 Cr

Return on Equity (ROE)

-6.33

PE Ratio (TTM)

-28.03

Return on capital employed (ROCE)

-6.3

Industry PE ratio

53.55

Beta (LTM)

0.95

P/B Ratio

3.09

Dividend Yield

0

PEG Ratio

8.17

Quarterly Earnings Growth YOY

83.74

EPS (TTM)

-7.37

Sector

Healthcare

Book Value

5.04

Technical Analysis

Suven Stock's Interest Amongst Investors

-38%

Period Aug 20, 2025 to Jul 21, 2025. Change in 30 Days vs previous period

Search interest for Suven Life Sciences Ltd Stock has decreased by -38% in the last 30 days, reflecting a downward trend in search activity.

Suven Stock Valuation

Track how Suven P/E has moved over time to understand its valuation trends.

Suven in the last 5 years

  • Overview

  • Trends

Lowest (-165.11x)

February 27, 2020

Today (-28.03x)

August 19, 2025

Industry (53.55x)

August 19, 2025

Highest (-6.67x)

March 27, 2023

LowHigh

Today’s Price to Earnings Ratio: -28.03x

Suven Life Sciences Ltd Financial Results

Get the annual and quarterly financial summary of Suven Life Sciences Ltd, including revenue, profit, loss and more.

Value in ₹ crore
DetailsQ1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26
Revenue

(in ₹ Cr)

1 (0%)3 (154%)2 (37%)1 (9%)2 (27%)
Net Income

(in ₹ Cr)

-28 (0%)-50 (77%)-39 (21%)-44 (12%)-52 (17%)
Net Profit Margin-2,776.24% (0%)-1,931.52% (30%)-2,429.81% (26%)-2,989.12% (23%)-2,755.08% (8%)
Value in ₹ crore
DetailsFY22FY23FY24FY25
Total Assets

(in ₹ Cr)

108 (0%)389 (260%)285 (27%)135 (53%)
Total Liabilities

(in ₹ Cr)

12 (0%)14 (14%)15 (10%)25 (69%)
Value in ₹ crore
DetailsFY21FY22FY23FY24FY25
Operating Cash Flow

(in ₹ Cr)

-37 (0%)-37 (0%)-23 (37%)-21 (10%)-47 (130%)

Suven Earnings and Dividends

View detailed summary of the earnings and dividend history of Suven.

  • Suven Life Sciences Ltd Earnings Results

    Suven Life Sciences Ltd’s net profit fell -83.74% since last year same period to ₹-51.52Cr in the Q1 2025-2026. On a quarterly growth basis, Suven Life Sciences Ltd has generated -17.25% fall in its net profits since last 3-months.

    Read More about Earnings Results
  • Suven Life Sciences Ltd Dividends February,2019

    In the quarter ending December 2018, Suven Life Sciences Ltd has declared dividend of ₹1.50 per share on 05 Feb 2019 - translating a dividend yield of 0.65%.

    Read More about Dividends

Indices Featuring Suven Stock

Check stock indices that include Suven.

BSE Small-Cap

₹53,021.43

0.97 (510.89%)

BSE Healthcare

₹44,589.54

0.11 (47.44%)

Suven Stock Shareholding Pattern

View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Suven.

InvestorsHoldings %Quarterly Trend3M change
Promoter Holdings
67.43%
-4.04
Foreign Institutions
0.56%
-4.92
Mutual Funds
2.08%
22004.26
Retail Investors
28.61%
-1.77
Others
1.33%
10885.95

Suven Life Sciences Ltd vs Peers

Compare market cap, revenue, PE, and other key metrics of Suven with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
NA5,159.6275.12%0.51-1616
NA55.69229.77%0.64316
NA43.0391.09%0.00NA18
BUY27,522.788.58%0.584963,642
NA23.55-7.33%0.001240

Suven News & Key Events

Latest news and events in one place to help you make informed investing decisions in Suven.

  • Suven Life Sciences Stock Shows Strong Momentum - 08 Jul, 2025

    Suven Life Sciences Ltd is experiencing significant buying interest, trading near its 52-week high. The stock has impressive growth potential, driven by its CNS drug pipeline, despite risks associated with unprofitability and market volatility.
  • Suven Life Sciences Ltd Declines Amid Market Trends - 23 Jun, 2025

    Suven Life Sciences Ltd fell 3.06% to Rs 220, while the BSE Healthcare index decreased by 1.34%. Despite this, Suven has gained 6% over the past month.
  • Suven Life Sciences Shares Surge to New Highs - 16 Jun, 2025

    Suven Life Sciences shares hit new highs, rising 9% to ₹257.70. The stock has surged 153% since April lows, driven by strong demand for CNS therapeutics amid rising prevalence of CNS disorders.

Insights on Suven Life Sciences Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, SUVEN has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, SUVEN has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 0.01% to 2.08% in Jul 2025 quarter

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 29.12% to 28.61% in Jul 2025 quarter

  • imgNEGATIVE IMPACT

    Promoter Holding Down

    img

    Promoters have decreased holdings from 70.27% to 67.43% in Jul 2025 quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 4 quarters, 6.61 Cr → 2.47 Cr (in ₹), with an average decrease of 25.4% per quarter

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 0.59% to 0.56% in Jul 2025 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, SUVEN stock has moved down by -19.3%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 3 quarters, -39.12 Cr → -51.52 Cr (in ₹), with an average decrease of 14.8% per quarter

About Suven Life Sciences Ltd

Suven Life Sciences Limited (erstwhile Suven Pharmaceuticals), established in 1989, is in the business of Contract Research and Manufacturing Services (CRAMS), providing process research and rapid response pilots scale 16 manufacture, custom synthesis, process R&D, and contract manufacturing of intermediates, APIs and formulations. It has two international wholly owned subsidiaries and one Indian wholly owned subsidiary. With the aim of expanding its drug discovery portfolio, a remarkable growth of 71% in total sales and a 325% growth in profit after tax (PAT) was registered during 2000-01. In addition, the company also acquired a pilot plant and got its recertification of ISO 9002 during the same year. In 2013-14, Suven granted an exclusive license to Taro Pharmaceuticals to market its product Head Lice Lotion in the US, Canada and Mexico, estimated at US$35million. During FY2014-15, one of its lead clinical candidates SUVN 502 has successfully completed the Phase 1b clinical trial, leading way for the entry into Proof of Concept (PoC) Phase 2a study. Thesaid year also saw the Company issuing and alloting 10, 453, 690 equity shares of Re 1/ each at a premium of Rs190.32 per share by way of QIP issue. In 2018-19, a Scheme of Arrangement for Demerger was initiated between Suven Life Sciences and Suven Pharmaceuticals Limited, resulting in a mirror shareholding of Suven Life Sciences in Suven Pharmaceuticals Limited. Consequently, Suven Pharmaceuticals Ltd., India and Suven Pharma Inc., USA became subsidiary companies of the group. As of 31st March 2019, investments were made to Suven Neurosciences Inc., a wholly owned subsidiary, amounting to Rs. 13, 636 lakh and no investments were made into newly formed Suven Pharma Inc., USA.

Revenue: ₹1.87Cr as on June 2025 (Q1 FY26)
Net Profit: ₹-51.52Cr as on June 2025 (Q1 FY26)
Listing date: 23 Oct, 2003
Chairperson Name: Venkateswarlu Jasti
OrganisationSuven Life Sciences Ltd
HeadquartersHyderabad
IndustryHealthcare
CEOVenkateswarlu Jasti
E-voting on sharesClick here to vote

Mutual Funds that own Suven Stock

Check out the Mutual Funds with significant holdings in Suven.

FAQs

What is Suven share price today?

Suven share price today stands at ₹236.6, Open: ₹231, Previous Close: ₹231.2, High: ₹242.7, Low: ₹227, 52 Week High: ₹299.99, 52 Week Low: ₹102.5 as on .

How to buy Suven shares ?

To buy Suven shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for SUVEN or Suven Life Sciences Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Suven shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is today's traded volume of Suven?

Today's traded volume of Suven is 1.12L. Which means that 1.12L shares of Suven were bought and sold on the stock market during today's trading session.

What is Suven's market cap today?

Today's market capitalisation of Suven is ₹5,159.62 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.

What is the 52 week high and 52 week low range of Suven?

Suven’s 52 week high is ₹299.99 and 52 week low is ₹102.5. The current share price of Suven is ₹236.6, which is -21.13% down from its 52 week high and 130.83% up from its 52 week low.